U.S. Arris Composites, a developer of next-generation composites for mass-market applications, has completed with $10 million in Series A funding round.

U.S. venture capital firm New Enterprise Associates led the financing round.

With the net proceeds raised from the round, Arris Composites will further extend its operations and development efforts.

Recently, New Enterprise Associates also led clinical-stage pharmaceutical company Reneo Pharmaceuticals' $50 million Series A funding.